Lyell Immunopharma, Inc.LL

Lyell Immunopharma, Inc.

0.7108USDR
−0.0020−0.28%
At close at Feb 28, 21:16 GMT
USD
No trades
See on Supercharts
Back

Operating income of Lyell Immunopharma, Inc.

Annual data
2020
2021
2022
2023
TTM
‪‪−280.00 M‬‬
‪‪−210.00 M‬‬
‪‪−140.00 M‬‬
‪‪−70.00 M‬‬
‪0.00‬
Period
Value
Change
Change %
TTM
‪‪−220.54 M‬‬
+‪‪30.19 M‬‬
+‪12.04‬%
2023
‪‪−250.73 M‬‬
‪‪−58.92 M‬‬
‪−30.72‬%
2022
‪‪−191.81 M‬‬
+‪‪25.29 M‬‬
+‪11.65‬%
2021
‪‪−217.10 M‬‬
+‪‪4.27 M‬‬
+‪1.93‬%
2020
‪‪−221.37 M‬‬
‪‪−119.28 M‬‬
‪−116.84‬%
Quarterly data
Q2 '20
Q3 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−68.00 M‬‬
‪‪−51.00 M‬‬
‪‪−34.00 M‬‬
‪‪−17.00 M‬‬
‪0.00‬
Period
Value
Change
Change %
Q3 '24
‪‪−51.27 M‬‬
+‪‪2.02 M‬‬
+‪3.79‬%
Q2 '24
‪‪−53.30 M‬‬
+‪‪2.84 M‬‬
+‪5.06‬%
Q1 '24
‪‪−56.14 M‬‬
+‪‪3.69 M‬‬
+‪6.17‬%
Q4 '23
‪‪−59.83 M‬‬
+‪‪747.00 K‬‬
+‪1.23‬%
Q3 '23
‪‪−60.58 M‬‬
+‪‪5.29 M‬‬
+‪8.03‬%
Q2 '23
‪‪−65.87 M‬‬
‪‪−1.42 M‬‬
‪−2.20‬%
Q1 '23
‪‪−64.45 M‬‬
‪‪−48.46 M‬‬
‪−302.98‬%
Q4 '22
‪‪−15.99 M‬‬
+‪‪50.69 M‬‬
+‪76.02‬%
Q3 '22
Q2 '22
Q1 '22
Q4 '21
Q3 '21
Q2 '21
Q1 '21
Q3 '20
Q2 '20